EQUINOX NEPREMICNINE d.d Future Growth
Future criteria checks 1/6
EQUINOX NEPREMICNINE d.d is forecast to grow revenue at 5.9% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Real Estate earnings growth | 61.7% |
| Revenue growth rate | 5.9% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 14 May 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 9 | N/A | 5 | 7 | 1 |
| 12/31/2025 | 9 | N/A | 4 | 9 | 1 |
| 12/31/2024 | 9 | N/A | 7 | 3 | 1 |
| 6/30/2024 | 8 | 1 | 6 | 6 | N/A |
| 3/31/2024 | 8 | 1 | N/A | N/A | N/A |
| 12/31/2023 | 8 | 1 | 6 | 6 | N/A |
| 3/31/2023 | 8 | 1 | N/A | N/A | N/A |
| 12/31/2022 | 7 | 1 | 8 | 8 | N/A |
| 12/31/2021 | 7 | 1 | 15 | 15 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if EQNX's forecast earnings growth is above the savings rate (2%).
Earnings vs Market: Insufficient data to determine if EQNX's earnings are forecast to grow faster than the SI market
High Growth Earnings: Insufficient data to determine if EQNX's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: EQNX's revenue (5.9% per year) is forecast to grow faster than the SI market (5% per year).
High Growth Revenue: EQNX's revenue (5.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if EQNX's Return on Equity is forecast to be high in 3 years time